Inactive
Notice ID:36C25723P0285
Acquisition Plan Action ID: 36C257-23-AP-2208 Contracting Activity: Department of Veterans Affairs Network Contracting Office 17 5441 Babcock Road, Ste. 302 San Antonio TX 78240 2237# 671-23-2-029-015...
Acquisition Plan Action ID: 36C257-23-AP-2208 Contracting Activity: Department of Veterans Affairs Network Contracting Office 17 5441 Babcock Road, Ste. 302 San Antonio TX 78240 2237# 671-23-2-029-0156 Brief Description of Supplies/ Services required and the intended use/Estimated Amount: The South Texas VA Health Care System (STVHCS) requires the manufacturing and delivery of radiopharmaceuticals for the diagnosis and treatment of various disease processes through Nuclear Medicine Imaging. The VA awards a firm-fixed-price purchase order, in accordance with FAR Parts 12 & 13. Delivery shall be made upon request of the STVHS. This action will serve as a short term contract pending full review of a GAO protest to award 36C25723C0042. Item Product Description 1 Ga-67 Gallium Citrate UD 2 I-123 Iobenguane Sulfate UD 3 I-123 USP NaI 100 uCi Cap 4 I-123 USP NaI 200 uCi Cap 5 I-123 RC NaI Cap (per mCi) 6 I-131 USP NaI DX Cap UD mCi 7 I-131 USP NaI DX Cap UD uCi 8 I-131 USP NaI TX Cap mCi 9 In-111 Chloride Point Source 10 In-111 Oxyquinoline Point Source 11 In-111 Autologous WBC Suspension UD 12 In-111 Pentetate (UD) SDV/Vial 13 Tc-99m Cardiolite UD 14 Tc-99m Exametazime WBC's UD 15 Tc-99m Filtered Sulfur Colloid UD 16 Tc-99m Filtered Sulfur Colliod (uCi) UD 17 Tc-99m Macro Aggregated Albumin UD 18 Tc-99m MAA Reduced Particle UD 19 Tc-99m Mebrofenin UD 20 Tc-99m Meriatide UD 21 Tc-99m NaTcO4 UD uCi 22 Tc-99m NaTcO4 UD mCi 23 Tc-99m Oxidronate UD 24 Tc-99m Penetate UD 25 Tc-99m Penetate (UD) (Aerosol) 26 Tc-99m Pyrophosphate UD 27 Tc-99m Sestamibi UD 28 Tc-99m Sulfur Colloid UD 29 Tc-99m Tetrofosmin UD 30 Tc-99m Tilmanocept UD syringe (Lymphoseek-proprietary product only sold by CAH)(Filtered sulfur colloid is the gold standard) 31 Tl-201 Thallous Chloride UD 32 Xe-133 Xenon Gas 20 mCi Vial 33 Xe-133 Xenon Gas 10 mCi Vial 34 Tc-99m Non-HEU Cardiolite (Sestamibi) UD 35 Tc-99m Non-HEU Macro Aggregated Albumin UD 36 Tc-99m Non-HEU MAA Reduced Particle UD 37 Tc-99m Non-HEU Mebrofenin UD 38 Tc-99m Non-HEU Medronate UD 39 Tc-99m Non-HEU Meriatide UD 40 Tc-99m Non-HEU NaTcO4 UD mCi 41 Tc-99m Non-HEU Oxidronate UD 42 Tc-99m Non-HEU Penetate UD 43 Tc-99m Non-Heu Penetate UD (Aerosol) 44 Tc-99m Non-HEU Pyrophosphate UD 45 Tc-99m Non-HEU Sestamibi UD 46 Tc-99m Non-HEU Sulfur Colloid UD 47 Tc-99m Non-HEU Filtered Sulfur Colloid UD 48 Tc-99m Non-HEU Tetrofosmin UD 49 Tc-99m Non-HEU Autologous WBC's Suspension 50 WBC Blood Kit 51 Ultravent Aerosol Nebulizer 52 Sincalide Solution (UD) - (dose) 53 Ultratag Kits 54 F-18 FDG UD 55 F-18 FDG UD Source 56 F18 NaF UD 57 Ga-68 DOTA-Octreotate Injection UD 58 DC Accuracy 59 DC Geometry 60 DC Linearity 61 After Hours Callout 62 After Hours Delivery Charge 63 Stat 64 Weekday Delivery 3 65 Weekday Delivery 4 66 Weekday Delivery 5 67 Weekend Delivery 3 68 Tc-99m Medronate UD Period of Performance: March 22, 2023 – June 21, 2023 Estimate Value: $219,525.44 Unique characteristics that limit availability to only one source, with the reason no other supplies or services can be used: Past market research has found SDVOSBs are not capable of providing all required radiopharmaceuticals needed for daily and clinical operations of Nuclear Medicine. It is required that this acquisition be an emergency sole source acquisition. The current contract was protested. There is a need to acquire an emergency sole source contract until the protest can be resolved. . The facility has a daily need for radiopharmaceutical drugs. It has been appropriately demonstrated that RLS USA, Inc is the sole manufacturer and distributor of the cancer treatment protocols. A short-term contract with RLS USA, Inc is in the best interest of the Government to facilitate uninterrupted cancer treatments for the affected Veterans. As noted above, this short term requirement is due to a GAO protest to award 36C25723C0042. Three vendor are potentially capable of performing this requirement. The deciding factors in determining which vendor would receive this emergency award are: 1. Price reasonableness 2. Current certifications, accreditations, and licensing 3. Demonstrated excellent past performance
